Yossi Maimon, VP, Chief Financial Officer at Protalix BioTherapeutics, Inc. (PLX), sold 125,964 shares at $7.13 ($898K) on 2012-05-02, disclosed to the SEC on 2012-05-04.
Scheduled sale ($898k) by VP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PLX | SELL | 2010-09-08 | $565K | — | Filing → |
| PLX | SELL | 2009-10-19 | $1.4M | — | Filing → |
| PLX | SELL | 2009-07-08 | $255K | — | Filing → |